Document is current
Any future updates will be listed below
-
Authors
Costa, Ana https://orcid.org/0000-0002-0893-3388
Thirant, Cécile https://orcid.org/0000-0003-3873-5240
Kramdi, Amira
Pierre-Eugène, Cécile
Louis-Brennetot, Caroline
Blanchard, Orphée
Surdez, Didier
Gruel, Nadege
Lapouble, Eve
Pierron, Gaëlle
Sitbon, Deborah
Brisse, Hervé
Gauthier, Arnaud
Fréneaux, Paul
Bohec, Mylène
Raynal, Virginie
Baulande, Sylvain
Leclere, Renaud
Champenois, Gabriel
Nicolas, Andre
Meseure, Didier
Bellini, Angela
Marabelle, Aurelien https://orcid.org/0000-0002-5816-3019
Geoerger, Birgit
Mechta-Grigoriou, Fatima
Schleiermacher, Gudrun
Menger, Laurie
Delattre, Olivier
Janoueix-Lerosey, Isabelle https://orcid.org/0000-0003-0434-3003
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03496402 at ClinicalTrials.govnct02613962 at ClinicalTrials.govDocuments that mention this clinical trial
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
https://doi.org/10.1136/jitc-2022-004807
Documents that mention this clinical trial
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
https://doi.org/10.1136/jitc-2022-004807
-
Funding
Funding for this research was provided by:
ITMO Cancer Aviesan
Ligue Contre le Cancer (Equipe labellisée)
European Research Council (Synergy program entitled "Kill or Differentiate")
Agence Nationale de la Recherche (ANR-10-EQPX-03)
Agence Nationale de la Recherche (ANR-10-INBS-09-08)
Institut National Du Cancer (INCa-DGOS- 4654)
Institut National Du Cancer (INCa-DGOS_8519)
Institut National Du Cancer (PEDIAC consortium, INCA_15670)
Institut National Du Cancer (PLBIO-18273)
Institut National Du Cancer (PRT-K14-061)
- License Information
